| # | Title | Journal | Year | Citations |
|---|
| 1 | Artificial intelligence in healthcare: past, present and future | Stroke and Vascular Neurology | 2017 | 2,009 |
| 2 | Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study | Stroke and Vascular Neurology | 2020 | 684 |
| 3 | China Stroke Statistics 2019: A Report From the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations | Stroke and Vascular Neurology | 2020 | 313 |
| 4 | Update on cerebral small vessel disease: a dynamic whole-brain disease | Stroke and Vascular Neurology | 2016 | 311 |
| 5 | Basement membrane and blood–brain barrier | Stroke and Vascular Neurology | 2019 | 182 |
| 6 | The Third China National Stroke Registry (CNSR-III) for patients with acute ischaemic stroke or transient ischaemic attack: design, rationale and baseline patient characteristics | Stroke and Vascular Neurology | 2019 | 171 |
| 7 | Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of ischaemic cerebrovascular diseases | Stroke and Vascular Neurology | 2020 | 151 |
| 8 | Iron toxicity, lipid peroxidation and ferroptosis after intracerebral haemorrhage | Stroke and Vascular Neurology | 2019 | 147 |
| 9 | Blood pressure gradients in cerebral arteries: a clue to pathogenesis of cerebral small vessel disease | Stroke and Vascular Neurology | 2017 | 125 |
| 10 | Consensus for prevention and management of coronavirus disease 2019 (COVID-19) for neurologists | Stroke and Vascular Neurology | 2020 | 119 |
| 11 | Neurotransmitter receptors on microglia | Stroke and Vascular Neurology | 2016 | 116 |
| 12 | Current management of spontaneous intracerebral haemorrhage | Stroke and Vascular Neurology | 2017 | 108 |
| 13 | Stroke-induced immunosuppression and poststroke infection | Stroke and Vascular Neurology | 2018 | 105 |
| 14 | Brain iron overload following intracranial haemorrhage | Stroke and Vascular Neurology | 2016 | 101 |
| 15 | China Stroke Statistics: an update on the 2019 report from the National Center for Healthcare Quality Management in Neurological Diseases, China National Clinical Research Center for Neurological Diseases, the Chinese Stroke Association, National Center for Chronic and Non-communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention and Institute for Global Neuroscience and Stroke Collaborations | Stroke and Vascular Neurology | 2022 | 97 |
| 16 | The American Heart Association’s Get With the Guidelines (GWTG)-Stroke development and impact on stroke care | Stroke and Vascular Neurology | 2017 | 95 |
| 17 | Chinese Stroke Center Alliance: a national effort to improve healthcare quality for acute stroke and transient ischaemic attack: rationale, design and preliminary findings | Stroke and Vascular Neurology | 2018 | 88 |
| 18 | Guidelines for evaluation and management of cerebral collateral circulation in ischaemic stroke 2017 | Stroke and Vascular Neurology | 2018 | 85 |
| 19 | Microglial activation after ischaemic stroke | Stroke and Vascular Neurology | 2019 | 82 |
| 20 | Updates in the management of cranial dural arteriovenous fistula | Stroke and Vascular Neurology | 2020 | 79 |
| 21 | Decline in stroke alerts and hospitalisations during the COVID-19 pandemic | Stroke and Vascular Neurology | 2020 | 72 |
| 22 | Eyes and stroke: the visual aspects of cerebrovascular disease | Stroke and Vascular Neurology | 2017 | 71 |
| 23 | Use of HINTS in the acute vestibular syndrome. An Overview | Stroke and Vascular Neurology | 2018 | 69 |
| 24 | Trend of declining stroke mortality in China: reasons and analysis | Stroke and Vascular Neurology | 2017 | 66 |
| 25 | Red blood cell distribution width and ischaemic stroke | Stroke and Vascular Neurology | 2017 | 66 |
| 26 | Arterial stiffness and stroke: de-stiffening strategy, a therapeutic target for stroke | Stroke and Vascular Neurology | 2017 | 62 |
| 27 | Blood pressure management in acute stroke | Stroke and Vascular Neurology | 2016 | 58 |
| 28 | The Chinese Stroke Association scientific statement: intravenous thrombolysis in acute ischaemic stroke | Stroke and Vascular Neurology | 2017 | 58 |
| 29 | Cerebral aneurysm treatment: modern neurovascular techniques | Stroke and Vascular Neurology | 2016 | 56 |
| 30 | How to identify which patients with asymptomatic carotid stenosis could benefit from endarterectomy or stenting | Stroke and Vascular Neurology | 2018 | 55 |
| 31 | Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial | Stroke and Vascular Neurology | 2017 | 53 |
| 32 | Exercise for stroke prevention | Stroke and Vascular Neurology | 2018 | 53 |
| 33 | Mechanisms of hydrocephalus after intraventricular haemorrhage in adults | Stroke and Vascular Neurology | 2016 | 51 |
| 34 | Chinese Atherosclerosis Risk Evaluation (CARE II) study: a novel cross-sectional, multicentre study of the prevalence of high-risk atherosclerotic carotid plaque in Chinese patients with ischaemic cerebrovascular events—design and rationale | Stroke and Vascular Neurology | 2017 | 49 |
| 35 | Clinical time course of COVID-19, its neurological manifestation and some thoughts on its management | Stroke and Vascular Neurology | 2020 | 49 |
| 36 | Prognostic value of systemic immune–inflammation index in acute/subacute patients with cerebral venous sinus thrombosis | Stroke and Vascular Neurology | 2020 | 48 |
| 37 | Determinants of the impact of blood pressure variability on neurological outcome after acute ischaemic stroke | Stroke and Vascular Neurology | 2017 | 44 |
| 38 | Poststroke seizure: optimising its management | Stroke and Vascular Neurology | 2019 | 44 |
| 39 | Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of stroke rehabilitation | Stroke and Vascular Neurology | 2020 | 44 |
| 40 | Stenting for symptomatic intracranial arterial stenosis in China: 1-year outcome of a multicentre registry study | Stroke and Vascular Neurology | 2018 | 43 |
| 41 | Update on cell therapy for stroke | Stroke and Vascular Neurology | 2017 | 42 |
| 42 | Diet for stroke prevention | Stroke and Vascular Neurology | 2018 | 42 |
| 43 | Safety and efficacy of Edaravone Dexborneol versus edaravone for patients with acute ischaemic stroke: a phase II, multicentre, randomised, double-blind, multiple-dose, active-controlled clinical trial | Stroke and Vascular Neurology | 2019 | 42 |
| 44 | Artificial intelligence and big data facilitated targeted drug discovery | Stroke and Vascular Neurology | 2019 | 42 |
| 45 | Cerebral microhaemorrhage in COVID-19: a critical illness related phenomenon? | Stroke and Vascular Neurology | 2020 | 41 |
| 46 | Sleep apnoea and stroke | Stroke and Vascular Neurology | 2016 | 40 |
| 47 | Shared decision-making in stroke: an evolving approach to improved patient care | Stroke and Vascular Neurology | 2017 | 40 |
| 48 | Efficacy and safety of intravenous recombinant tissue plasminogen activator in mild ischaemic stroke: a meta-analysis | Stroke and Vascular Neurology | 2018 | 38 |
| 49 | Migraine and stroke | Stroke and Vascular Neurology | 2017 | 37 |
| 50 | Safety and efficacy of tenecteplase versus alteplase in patients with acute ischaemic stroke (TRACE): a multicentre, randomised, open label, blinded-endpoint (PROBE) controlled phase II study | Stroke and Vascular Neurology | 2022 | 37 |
